Caldwell Trust’s Carter's CRI Stock Holding History

Caldwell Trust’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-137	Closed	-$9.66K	–	727
2022 Q2	$9.66K	Buy	+137	New	+$11K	﹤0.01%	629

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Caldwell Trust's CRI Position: Q3 2022 in Review

Caldwell Trust sold out of Carter's (CRI) in Q3 2022, closing a stake of 137 shares — an estimated $9.66K sold.

Caldwell Trust first reported a position in CRI in Q2 2022 and held it in 1 quarter. The position peaked at $9.66K in Q2 2022. 298 funds tracked by Wall St. Rank hold CRI as of Q3 2022.

Caldwell Trust reported no remaining Carter's position as of Q3 2022 after selling out during the quarter.
Caldwell Trust sold 137 Carter's shares in Q3 2022, an estimated $9.66K.
Caldwell Trust first reported a position in Carter's in Q2 2022 and held it in 1 quarter.
Caldwell Trust's Carter's position peaked at $9.66K in Q2 2022.
298 funds tracked by Wall St. Rank held Carter's as of Q3 2022.

Based on Caldwell Trust's 13F filing for Q3 2022, filed 1 Oct 2025.